SAHPRA Warns Against Counterfeit Versions of Ozempic and Mounjaro.
Johannesburg: The South African Health Products Regulatory Authority (SAHPRA) has raised alarms over the rising availability of counterfeit Glucagon-like Peptide-1 (GLP-1) products, including Ozempic, in